Study | Setting | Total patients (n) | Females (n) | SDB (AHI ≥15/h) | ß-blocker | Spironolactone |
---|---|---|---|---|---|---|
Schulz et al. 2007 [37] | Multicenter | 203 | 51 | -* | 90% | 46% |
Javaheri et al. 2006 [38] | Single center | 100 | 0 | 49% | 10% | 0% |
Oldenburg et al. 2007 [6] | Single center | 700 | 139 | 51% | 85% | 62% |
Sin et al. 1999 [39] | Single center | 450 | 68 | 61% | 0% | 0% |
Yumino et al. 2009 [40] | Single center | 218 | 50 | 47% | 75% | 21% |
Paulino et al. 2009 [41] | Single center | 316 | 55 | -* | 82% | 58% |
Dolliner et al. 2013 [42] | Single center | 176 | 26 | 50% | 90% | 60% |